RACC trial

[RACC trial @RaccTrial]

First publication from the RACC-trial show fewer intraoperative complications after robot-assisted surgery while postoperative morbidity was similar between the approaches. Small differences in HRQOL favoured robotic surgery. https://t.co/vC0uwSB92M

[Henrik Falconer @falconer_henrik]

First cohort study comparing TMMR with standard treatment for cervical cancer published in Lancet journal eClinicalMedicine - time to reconsider primary treatment.
Outstanding collaboration with the Leipzig team led by Michael Höckel and Bahriye Aktas!

https://t.co/z68Z2NNfov

[RACC trial @RaccTrial]

@ChristinaUwins @leitaomd @falconer_henrik According to the statistical plan, data should be available 2027

[RACC trial @RaccTrial]

In less than 5 years, the RACC-trial reached the preplanned study population of 768 women a few days ago. The commitment from all 29 participating sites has been extraordinary - look forward to the next steps in RACC!

[RACC trial @RaccTrial]

@BoriaFelix @leitaomd @agz_eriksson @GynMe4 @me4_so @SERGS_org Don’t know how the ROCC trial is doing and with less than 70 patients to go, we have closed the trial for new centers

[RACC trial @RaccTrial]

700 enrolled patients in the RACC-trial thanks to extraordinary efforts by all teams! Now just 68 more to go!

[RACC trial @RaccTrial]

Less than 100 to go! Fabulous accrual past months and we should reach 700 before the end of 2023. Keep up the good work!

[RACC trial @RaccTrial]

601! Accrual rate continues to exceed all expectations, fabulous work by all participating sites!

[RACC trial @RaccTrial]

@AndreasObermair Alternatively, with no differences at all between arms, surgeons/patients could choose any approach.

[RACC trial @RaccTrial]

500! The RACC-trial reached the magic milestone earlier today, well done Aarhus and a massive thanks to all participating centers!

[RACC trial @RaccTrial]

@AndreasObermair Indeed, if non-inferiority regarding oncologic outcomes can be demonstrated, secondary endpoints should preferably favour the experimental arm.

[RACC trial @RaccTrial]

@BatistaTP @sbco_oficial @CBCcirurgioes @br_gynoncgroup @eLightICG The trial recruits ahead of schedule, looking at closing late 2023/early 2024

[RACC trial @RaccTrial]

Earlier today, the 8th European country joined the RACC-trial when Denmark and Arhus UH with PI Pernille Jensen randomised their first patient! Well done and welcome to the trial!

[RACC trial @RaccTrial]

@AndreasObermair @leitaomd The potential in novel technology? Problem is that we can’t measure potential

[RACC trial @RaccTrial]

@AndreasObermair @leitaomd Indeed. But perhaps we sometimes look in the wrong direction when it comes to benefits of novel technology?

[RACC trial @RaccTrial]

@leitaomd Yes, first interim was recently approved by the DSMB

[RACC trial @RaccTrial]

The RACC-trial just passed 400 enrolled patients! A huge thank you to all participating sites, see you in Stockholm January 2023!

[RACC trial @RaccTrial]

The RACC-trial reaches 50%! The 384th and 385th patients were randomised earlier today and we now have less than half remaining. With current accrual, we should be able to close late 2023. Fabulous work by all participating centres!

[RACC trial @RaccTrial]

All time high enrolment in April! 21 patients included, well done! We expect to reach 50% within 2-3 months

[RACC trial @RaccTrial]

@BatistaTP @IGCSociety @IJGConline @GynMe4 @eLightICG @glaucobaiocchi @sbco_oficial @br_gynoncgroup @HsuMd @PayamKashiMD @pedroramirezMD @leitaomd @TeamEndo_MSK The protocol doesn’t explicitly describe indications for adjuvant therapy based on nodal status, especially since ITC appears to be a moving target

[RACC trial @RaccTrial]

An important milestone was reached today as the 300th patient was enrolled in the RACC-trial! Amazing work by all participating sites! Next goal is 50%, should be reached within 4-5 months